Czechia, Dec. 9 -- Czechia based ROCHE s.r.o. has secured contract from Revmatologicky ustav for Antineoplastic and immunomodulating agents - Drug deliveries - ROACTEMRA 2025. The value of the contract is worth 7632000000 CZK.
Published by HT Digital Content Services with permission from Pivotal Sources....